Delivery Order SPE2DB22D1202-SPE2DB25FURY2

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products, with a total ceiling value of $20,005.08. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,604.16, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,109.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $1,580.64, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a firm fixed-price basis. This delivery order contract has a completion date of June 6, 2024 and does not utilize any set-aside designations....
This federal contract award is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,738.30 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 28, 2024. The contract has a period of performance through February 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $11,915.79 and a performance period through January 28, 2025. The contract is not designated as a set-aside and was awarded as an open competition. AmerisourceBergen also holds a...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024 with a ceiling value of $8,498.49. The contract is a delivery order with a firm fixed price, and there was no set-aside used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,927.27, is for the provision of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products, with a ceiling value of $1,192.35. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $17,793.65 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products, with a period of performance through January 2, 2025. This Delivery Order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FURY2
    Delivery Order

This contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contracting agency is the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense.

The contract is a Delivery Order with a Firm Fixed Price of $46,395.08 and a performance period ending on February 6, 2025. It is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/7/25, 9:58 AM